4//SEC Filing
Powchik Peter 4
Accession 0001437749-23-028074
CIK 0001851657other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 9:42 PM ET
Size
5.5 KB
Accession
0001437749-23-028074
Insider Transaction Report
Form 4
Vaxxinity, Inc.VAXX
Powchik Peter
Director
Transactions
- Award
Stock option (right to buy)
2023-10-02+159,744→ 159,744 totalExercise: $1.27→ Class A common stock (159,744 underlying)
Footnotes (3)
- [F1]These options were granted following the Reporting Person joining the Issuer's leadership team as Executive Vice President, Global Scientific Director, effective October 1, 2023, while remaining a member of the Issuer's board of directors.
- [F2]These options vest in 12 equal monthly installments beginning on October 1, 2023.
- [F3]These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates.
Documents
Issuer
Vaxxinity, Inc.
CIK 0001851657
Entity typeother
Related Parties
1- filerCIK 0001377247
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 9:42 PM ET
- Size
- 5.5 KB